Ameritas Investment Partners’s Armata Pharmaceuticals ARMP Stock Holding History

Ameritas Investment Partners’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.97K	Buy	+1,076	New	+$9.87K	﹤0.01%	3064

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Ameritas Investment Partners's ARMP Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 1,076 shares worth $6.97K. The stake represents ﹤0.01% of the portfolio and ranks #3064 among its holdings.

53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

Ameritas Investment Partners held 1,076 shares of Armata Pharmaceuticals worth $6.97K as of Q2 2026.
Armata Pharmaceuticals was a new Ameritas Investment Partners position in Q2 2026.
Armata Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #3064 holding.
53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.